Metabolic-associated fatty liver disease in patients undergoing hemodialysis: A cross-sectional study of prevalence and diagnostic accuracy of the triglyceride–glucose index
Metabolic dysfunction-associated fatty liver disease (MAFLD) is increasingly recognized in patients with metabolic and renal disorders; however, data in hemodialysis populations remain limited. This study assessed the prevalence of MAFLD in patients receiving maintenance HD and identified factors associated with its pr...